Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Harms

Showing results (181-190 of 258) with videos related to

Pageof 26
Sort By:
Molecular Cancer Research : MCR|August 5, 2017
Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable <i>FGFR3</i> AmplificationsLorena Lazo de la Vega, Jonathan B McHugh, Andi K Cani, et al.
BMC Immunology|January 9, 2019
Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infectionRaghubendra Singh Dagur, Amanda Branch-Woods, Saumi Mathews, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 14, 2020
Cutaneous manifestations of hospitalized coronavirus disease 2019 patients: a report of six cases with clinicopathologic features and viral RNA in situ hybridizationC Bitar, M P Chan, P W Harms, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivationPaul W Harms, Angela M B Collie, Daniel H Hovelson, et al.
Carcinogenesis|June 12, 2021
Constitutive Hedgehog/GLI2 signaling drives extracutaneous basaloid squamous cell carcinoma development and bone remodelingMarina Grachtchouk, Jianhong Liu, Mark E Hutchin, et al.
Human Pathology|February 24, 2015
Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal lossesPaul W Harms, Douglas R Fullen, Rajiv M Patel, et al.
The American Journal of Surgical Pathology|September 7, 2017
Solitary Fibrous Tumors of the Head and Neck: A Multi-Institutional Clinicopathologic StudySteven C Smith, William E Gooding, Matthew Elkins, et al.
Human Pathology|April 13, 2016
Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutationsPaul W Harms, Daniel H Hovelson, Andi K Cani, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 19, 2020
DNA copy number changes correlate with clinical behavior in melanocytic neoplasms: proposal of an algorithmic approachAhmed K Alomari, Jayson R Miedema, Michael D Carter, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 22, 2026
Spatially controlled induction and regression of basal cell carcinoma, visualized by serial imaging in young and old miceElisabeth A Pedersen, Marina Grachtchouk, Paul W Harms, et al.
Pageof 26

Showing results (181-190 of 258) with videos related to

Sort By:
Pageof 26
Molecular Cancer Research : MCR|August 5, 2017
Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable <i>FGFR3</i> AmplificationsLorena Lazo de la Vega, Jonathan B McHugh, Andi K Cani, et al.
BMC Immunology|January 9, 2019
Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infectionRaghubendra Singh Dagur, Amanda Branch-Woods, Saumi Mathews, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 14, 2020
Cutaneous manifestations of hospitalized coronavirus disease 2019 patients: a report of six cases with clinicopathologic features and viral RNA in situ hybridizationC Bitar, M P Chan, P W Harms, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivationPaul W Harms, Angela M B Collie, Daniel H Hovelson, et al.
Carcinogenesis|June 12, 2021
Constitutive Hedgehog/GLI2 signaling drives extracutaneous basaloid squamous cell carcinoma development and bone remodelingMarina Grachtchouk, Jianhong Liu, Mark E Hutchin, et al.
Human Pathology|February 24, 2015
Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal lossesPaul W Harms, Douglas R Fullen, Rajiv M Patel, et al.
The American Journal of Surgical Pathology|September 7, 2017
Solitary Fibrous Tumors of the Head and Neck: A Multi-Institutional Clinicopathologic StudySteven C Smith, William E Gooding, Matthew Elkins, et al.
Human Pathology|April 13, 2016
Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutationsPaul W Harms, Daniel H Hovelson, Andi K Cani, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 19, 2020
DNA copy number changes correlate with clinical behavior in melanocytic neoplasms: proposal of an algorithmic approachAhmed K Alomari, Jayson R Miedema, Michael D Carter, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 22, 2026
Spatially controlled induction and regression of basal cell carcinoma, visualized by serial imaging in young and old miceElisabeth A Pedersen, Marina Grachtchouk, Paul W Harms, et al.
Pageof 26